Manuscripts
Showing 1595 manuscripts.
Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings
Citation
Anish P. Mahajan, M.D., M.P.H., Joseph W. Hogan, Sc.D., Brad Snyder, M.S., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Kalindi Mehta, M.D., Suniti (Daralak) Solomon, M.D., Charles Carpenter, M.D., Kenneth H. Mayer, M.D., Timothy P. Flanigan, M.D. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2004 May 01; 36(1):567-75.Year
2004
Journal
Journal of Acquired Immune Deficiency Syndromes
Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy
Citation
Richard A. Zuckerman, William L.H. Whittington, Connie Celum, M.D., Tarquin Collis, Aldo J. Lucchetti, M.D., Jorge L. Sanchez, M.D., M.P.H., James P. Hughes, Jose L. Sanchez, Robert W. Coombs, M.D., Ph.D. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. Journal of Infectious Diseases. 2004 Jul 01; 190(1):156-61.Year
2004
Journal
Journal of Infectious Diseases
Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains
Citation
Susan H. Eshleman, M.D., PH.D., John Hackett, Jr., Priscilla Swanson, Shawn P. Cunningham, B.S., M.T., Sushil G. Devare, Catherine Brennan, Birgit Drews, Leopold Zekeng, Lazare Kaptue. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. Journal of Clinical Microbiology. 2004 Jun 01; 42(6):2711-7.Year
2004
Journal
Journal of Clinical Microbiology
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine
Citation
Ulrich A. Walker, J. Bauerle, M. Laguno, J. Murillas, Stefan Mauss, M.D., G. Schmutz, B. Setzer, R. Miquel, Jose M. Gatell Artigas, M.D., Ph.D., J. Mallolas. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology. 2004 Feb 01; 39(2):311-7.Year
2004
Journal
Hepatology
Pharmacokinetics and Tolerance of Zidovudine in Preterm Infants
Citation
Edmund Capparelli, Pharm.D., Mark Mirochnick, M.D., Wayne M. Dankner, M.D., Wayne Mathew Dankner, M.D., Suzette Blanchard, M.S., Ph.D., Suzette Blanchard, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Lynne M. Mofenson, M.D., F.A.A.P., George D. McSherry, M.D., George D. McSherry, M.D., Hannah Gay, M.D., Gregory Ciupak, B.A., Gregory Ciupak, B.A., Hannah Gay, M.D., Gregory Ciupak, B.A., Elizabeth (Betsy) Smith, M.D., Elizabeth Smith, M.D., James D. Connor, M.D., Barbara A. Smith, James D. Connor, M.D., Mark Mirochnick, M.D. Pharmacokinetics and Tolerance of Zidovudine in Preterm Infants. Journal of Pediatrics. 2003 Jan 03; 142((1)):47-52.Year
2003
Journal
Journal of Pediatrics
Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy
Citation
Christina M. Marra, M.D., D. Lockhart, M.S., J. R. Zunt, M.D., Margot Perrin, R.N., B.S.N., Robert W. Coombs, M.D., Ph.D., Ann C. Collier, M.D. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003 Apr 22; 60(8):1388-90.Year
2003
Journal
Neurology
Lymphocyte subsets in healthy children from birth through 18 years of age: the PACTG 1009 Study.
Citation
William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Rebecca S. Gelman, Ph.D., Rebecca Oyomopito, M.S., Susan Plaeger, Ph.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Bobbie L. Graham, B.S., Stephen A. Spector, M.D. Lymphocyte subsets in healthy children from birth through 18 years of age: the PACTG 1009 Study. Journal of Allergy and Clinical Immunology. 2003 Nov 01; 112:973-80.Year
2003
Journal
Journal of Allergy and Clinical Immunology
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.
Citation
C. Soh, James M. Oleske, M.D., Michael T. Brady, M.D., Stephen A. Spector, M.D., William Borkowsky, M.D., Sandra K. Burchett, M.D., M.S., M. Foca, Edward Handelsman, M.D., Eleanor Jimenez, M.D., F.A.A.P., Wayne Mathew Dankner, M.D., Michael Hughes, Ph.D. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet. 2003 Dec 20; 362(9401):2045-2051.Year
2003
Journal
Lancet
Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent viral load, and age.
Citation
David Dunn, Ross E. McKinney, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., John ( Jack ) Moye, Jr., M.D., Paul Palumbo, M.D., William T. Shearer, M.D., Ph.D. Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent viral load, and age. Lancet. 2003 Nov 15; 362(9396):1605-11.Year
2003
Journal
Lancet
Effect of cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival.
Citation
Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., David E. Shapiro, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Robert W. Coombs, M.D., Ph.D., Lisa M. Frenkel, M.D., Mary Glenn Fowler, M.D., M.P.H., Sharon Huang, M.S., Rhoda S. Sperling, M.D., Bethann Cunningham, B.S., Jorge Gandia, M.D., Robert T. Maupin, Jr., M.D., Carmen D. Zorrilla, M.D., Theodore Benjamin Jones, M.D., F.A.C.O.G., Mary Jo O'Sullivan, M.D. Effect of cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival. Journal of Acquired Immune Deficiency Syndromes. 2003 Sep 05; 32(2):170-181.Year
2003
Journal
Journal of Acquired Immune Deficiency Syndromes